×

Government policy, not consumer behaviour, is driving rising Medicare costs

By Professor Stephen Duckett, Director, Health Program, Grattan Institute

This article first appeared in The Conversation on 2 December, 2015, and can be viewed at: https://theconversation.com/government­policy­not­consumer­behaviour…

Announcing the ill-­fated 2014 budget initiative to introduce a consumer co-­payment for general practice visits, the-then Health Minister, Peter Dutton, lamented that annual Commonwealth health costs had increased from $8 billion to $19 billion over a decade.

He described the increase as “unsustainable”, and used it to justify the Budget’s bitter pill.

The implication of his announcement was that consumers were driving the increase in costs, and that action to change consumer behaviour was necessary to rein them in.

The growth numbers were presented as part of the government’s then mantra of a “debt and deficit disaster”, and massaged to create maximum shock and awe. The minister’s numbers did not adjust either for population growth or inflation.

Nonetheless, a more legitimate set of growth numbers would still show Medicare Benefits Schedule (MBS) payments growing at an annual rate of 2.3 per cent in real per ­head terms, faster than growth in Government expenditure overall (1.8 per cent).

But this still leaves open the question of whether consumer behaviour is driving rising costs, or whether there may be other causes.

A report released in late November by the Parliamentary Budget Office shows that Government policy has driven a significant proportion of the growth in MBS costs. In fact, of the $325 real increase in MBS spending per head since 1993-­94, all but $74 has been the result of explicit government decisions.

MBS spending per head is the product of the rebate for each MBS item and the per head use of those items. Both elements of this calculation have been tinkered with as part of policy change over the last two decades.

A significant proportion of the growth in Medicare costs has been driven by Government policies such as items for new services and larger rebates.

Governments have increased rebates for some items faster than inflation. This has been done, for example, to encourage an increased rate of bulk billing.

New item numbers have also been added as part of major policy reviews. (Each MBS service involves one or more item numbers and an associated description. For example, an ordinary consultation with a general practitioner is item number 24.) The single largest cost impact ($51 per head) came from changes to diagnostic imaging items, including new items for magnetic resonance imaging (MRI).

But implementation of policies to expand magnetic resonance imaging and reform diagnostic imaging items more generally has been poor. It is questionable whether consumers are getting value for money from this investment. Also, some diagnostic imaging tests appear to be overused.

Policies designed to increase bulk billing accounted for an extra $70 per head: increasing the GP rebate from 85 per cent of the schedule fee to 100 per cent accounted for $42 per head; targeted increases in the rebate to increase bulk billing rates accounted for the rest.

When did Medicare spending soar?

In the decade to 2003-044, Medicare spending grew by $53 per head. Just over half of that was attributable to the addition of new diagnostic imaging items to the schedule. In the next decade, spending grew at five times that rate – by $272 per head.

Most of the growth was due to decisions taken when Tony Abbott was Health Minister, between 2003 and 2007. In fact, almost half (47 per cent) of the growth in Medicare spending over the last two decades is the result of policy decisions taken when he was running the health portfolio.

The changes were introduced over the years for a mix of policy and political reasons.

The decline in bulk billing was associated with public dissatisfaction with Medicare and was clearly having political impacts. This led to new bulk billing incentives and increases to the rebates for general practitioner fees.

The increasing prevalence of chronic diseases, such as diabetes and heart disease, led to new assessment and care planning items.

A decline in the proportion of GPs providing after­-hours care led to new items to redress that as well.

General practitioners got more rebate income (in real terms) for seeing the same number of patients, so it was actually changes initiated by Government that led to the increase in spending.

What does this mean for Medicare reform?

Two main lessons can be drawn from the Parliamentary Budget Office report.

First, the Government must be clear about what is driving growth in expenditure. The co-payment proposal sank like a lead balloon partly because it was seen as inefficient and unfair, but also because the public didn’t have any ownership of the “problem” the changes sought to address. The way the problem was initially presented was wrong, causing confusion between Medicare services (which include diagnostic tests) and GP visits. The vast majority of the population, who have few visits, refused to accept that per ­head use was going up.

Second, the report shows how much governments have relied on tinkering with the Medicare Benefits Schedule to drive system change in the last decade. “Here a new item, there a new item, everywhere a new item”, became the Canberra policy song sheet.

Health Minister Sussan Ley wiped the slate clean when she was appointed in December, setting up a raft of reviews to look at everything from primary care to disinvestment.

Importantly, reviews must consider whether the Medicare Schedule is still “fit for purpose” in the context of the increase in chronic disease and the impact this is having on clinical practice.

It must be hoped new policies developed in response will be both more sophisticated and less profligate than we have seen over recent decades.

Health gets a guernsey in Paris

The right to health has been explicitly recognised in the agreement negotiated at the United Nations Paris climate change talks, boosting hopes of an increasing focus on the health effects of global warming.

In its preamble, the Paris Agreement directed that, when taking action on climate change, signatories should “respect, promote and consider their respective obligations on…the right to health”.

Director of the World Health Organisation’s Department of Public Health, Environmental and Social Determinants of Health, Dr Maria Neira, hailed the declaration as a “breakthrough” in recognising the health effects of climate change.

“This agreement is a critical step forward for the health of people everywhere,” Dr Neira said. “The fact that health is explicitly recognised in the text reflects the growing recognition of the inextricable linkage between health and climate.”

Dr Neira said that health considerations were essential to effective plans to adapt to climate change and mitigate its effects, and “better health will be an outcome of effective policies”.

Under the Paris deal, countries have expressed an “ambition” to limit global warming to less than 2 degrees Celsius, the point at which science suggests climate change becomes untenably dangerous.

While avoiding setting an explicit target, the signatory countries, including Australia, committed to “pursuing efforts to limit the temperature increase to 1.5 degrees Celsius”.

Attempts to orchestrate concerted global climate change action have in the past been frustrated by arguments over who should bear the greatest responsibility for causing climate change and, as a consequence, who carries the greatest obligation to ameliorate its effects.

Developing countries have argued that industrialised nations have become rich on fossil fuel-based economic activity and should bear the greater share of the burden in adopting to its consequences.

But developed countries have countered that any progress they make in curbing greenhouse gas emissions should not be simply offset by an increase in emissions from emerging economies.

The Paris agreement has sought to break the impasse by detailing a framework of “differentiated responsibilities” for climate action. Developed countries are expected to take the lead in reducing greenhouse gas emissions, but developing nations are also expected to contribute.

To help drive the global response, it is expected that by 2020, countries will contribute $US100 billion a year to a global fund to help finance emission reduction and climate change adaptation measures.

Though the agreement does not include any enforcement mechanism, countries are required to provide an update on their climate change action each five years, and each successive update has to be at least as strong as the current one, leading to what the framers of the document will be a “ratcheting up” of measures over time.

The promising outcome to the Paris meeting followed a call by the AMA and other peak medical groups worldwide for more concerted action to prepare for and mitigate the health effects of climate change.

In an updated Position Statement on Climate Change and Human Health released last year, the AMA highlighted multiple health threats including increasingly frequent and severe storms, droughts, floods and bushfires, pressure on food and water supplies, rising vector-borne diseases and climate-related illnesses and the mass displacement of people.

AMA President Professor Brian Owler said significant health and social effects of climate change were already evident, and would only become more severe over time.

“Nations must start now to plan and prepare,” Professor Owler said. “If we do not get policies in place now, we will be doing the next generation a great disservice. It would be intergenerational theft of the worst kind – we would be robbing our kids of their future.”

The AMA’s Position Statement on Climate Change and Human Health can be viewed at:  position-statement/ama-position-statement-climate-change-and-human-health-2004-revised-2015

Adrian Rollins

Infectious bacteria found in sticky situation

Sticky fingers are unavoidable when indulging in sugar coated sweets, but scientists have discovered that some infectious disease causing-bacteria use this sticky situation to their advantage.

Pathogenic bacteria has been found to initiate infection in a rather unique way – it uses its surface sugars to attach bacteria directly to sugars on the surface of human cells.

Researchers have found that four different types of bacteria pathogens: Campylobacter jejuni, Salmonella typhimurium, Shigella flexneri and Haemophilius influenzae, use this method to spread infection.

University of Adelaide researchers found that the Shingella flexneri bacteria, which causes millions of episodes of dysentery each year, use sugars of their surface lipopolysaccharide molecules to stick to human gut cells.

There is no Shingella vaccine currently available despite decades of research worldwide, and the bacteria can be resistant to antibiotics. The researchers hope their new understanding of how the bacteria spreads will advance progress towards a vaccine and other ways to block the sugars.

Lead researcher Associate Professor Renato Morona said that “as a result of the discovery we now have a better understanding of how bacteria initiate infections and how many current vaccines work”.

“It’s been known for a long time that sugars on the surface of bacteria can be involved in bacteria sticking to cells, to promote infections,” Associate Professor Morona told Adelaide Advertiser.

“What hasn’t been realised is that these sugars are often sticking to is sugars on the surface of cells.”

Associate Professor Morona said that while bacteria were known to use sugars to attach proteins, any sugar-to-sugar interaction was considered either impossible, weak, or irrelevant.

“The discovery is fundamental knowledge that is broadly applicable to many other bacteria and microbes, and could have other translational outcomes such as probes for studying human cells, and development of better infant milk formula,” Associate Professor Morona said.

The research was supported by the National Health and Medical Research Council. The team has received a four-year grant to explore the potential of their discovery.

The University of Adelaide in collaboration with Griffith University published the research in the Proceedings of the National Academy of Sciences journal.

Kirsty Waterford

 

[Comment] Universal access to medicines

Medicines account for 20–60% of health spending in low-income and middle-income countries, whereas in high-income countries the proportion is 18% or lower.1 Up to 90% of low-income populations purchase medicines through out-of-pocket payments, making medicines the largest household expenditure item after food.1 Strategies to make medicines more available and affordable are therefore crucial in increasing their use in low-income and middle-income countries, in which the burden of non-communicable diseases, in addition to awareness of the benefits of prevention and treatment, are increasing.

[Correspondence] Future inequalities in life expectancy in England and Wales – Authors’ reply

The observed closing of the life expectancy gap between men and women in our study of life expectancy trends in England and Wales,1 and the projections that this closing will continue, are consistent with data in other populations with small mortality differences between men and women.2,3 Investigators of the most recent of such reports concluded that “the current excess of female life expectancy in adulthood is a relatively new demographic phenomenon”.2 The divergence and reconvergence of male–female mortality is well known to be largely due to different levels and trends in deaths from external causes (injuries) and from disorders such as lung cancer and cardiovascular diseases, for which risk factors (eg, smoking) have different trends in men and women.

[Comment] China Diabetes Society 2016: a call for papers

Two decades ago, it seemed almost inconceivable that China would be heading towards an epidemic of obesity and type 2 diabetes; HIV/AIDS and other communicable diseases were much greater concerns. Rapid economic growth and investment in health systems have led to growing income, rapidly declining infectious disease rates, and increasing life expectancy.1 This good news story, however, carries with it the baggage of an increasing burden of obesity and diabetes. In 1994, it was estimated that the prevalence of diabetes was 2·5%.

[Comment] Offline: Chronic diseases—the social justice issue of our time

It would be normal to be anxious at a meeting about chronic diseases. Even overwhelmed. Non-communicable diseases (NCDs) are many—cardiovascular, cancer, diabetes, respiratory, liver, renal, neurological. The list goes on. And then there are risk factors: tobacco, diet, physical inactivity, high blood pressure, air pollution. The context only adds to the complexity—rapid globalisation, urbanisation, an ageing society. If you were a minister of health amid this extraordinary diversity of challenges, where would you begin? Last week, WHO held a “dialogue” to discuss the Global Coordination Mechanism on the Prevention and Control of Non-communicable Diseases.

Health neglected in climate talks

More than half of governments around the world are yet to develop national plans to protect their citizens from the health effects of climate change despite increasing warnings it will cause more extreme weather, spread disease and put pressure on food and water supplies.

As leaders from around the world attending the United Nations Climate Change Conference in Paris reaffirmed their commitment to provide $139 billion a year by 2020 to the UN’s Green Climate Fund and other climate initiatives, an international survey of 35 countries, including Australia, has found a general lack of focus and urgency around the looming threat of climate change to health, with most governments doing little work on likely effects and how to mitigate them.

The survey results underline calls from the AMA, the World Medical Association and other national medical organisations for the health effects of climate change to be made a priority.

AMA President Professor Brian Owler said that while much of the Paris talks were about carbon emission targets, there should be equal emphasis on equipping health systems to cope with the extra burden of problems created by climate change.

“Climate change will dramatically alter the patterns and rate of spread of diseases, rainfall distribution, availability of drinking water and drought,” Professor Owler said. “The incidence of conditions such as malaria, diarrhoea and cardio-respiratory problems is likely to rise.”

The AMA President’s comments came as a survey coordinated by the World Federation of Public Health Associations (WFPHA) found almost 80 per cent of governments are yet to comprehensively assess the threat climate change poses to the health of their citizens, two-thirds had done little to identify vulnerable populations and infrastructure or examine their capacity to cope, and less than half had developed a national plan.

The result underlines the importance of repeated AMA calls for the Federal Government to do much more to prepare for the effects of climate change, which Professor Owler said were “inevitable”.

Earlier this year the AMA released an updated Position Statement on Climate Change and Human Health that warned of multiple risks including increasingly frequent and severe extreme weather events, deleterious effects on food production, increased pressure on scarce water resources, the displacement of people and an increase in health threats such as vector-borne diseases and climate-related illnesses.

“There are already significant health and social effects of climate change and extreme weather events, and these effects will worsen over time if we do not take action now,” Professor Owler said.

“Nations must start now to plan and prepare. If we do not get policies in place now, we will be doing the next generation a great disservice.

“It would be intergenerational theft of the worst kind — we would be robbing our kids of their future.”

In May, the AMA and the Australian Academy of Science jointly launched the Climate change challenges to health: Risks and opportunities report that detailed the likely health effects of climate change and called for the establishment of a National Centre of Disease Control to provide a national and coordinated approach to threat.

The WFPHA said the results of its survey should serve as a wake-up call for governments to do much more.

“The specifics of these responses provide insight into the lack of focus of national governments around the world on climate and health,” the Federation said.

Disturbingly, the survey found that Australia was one of the laggards in addressing the health effects of climate change, having done little to assess vulnerabilities and long-term impacts, develop an early warning system or adaptation responses, and yet to establish a health surveillance plan.

On many of these measures, the nation was lagging behind countries like the United States, Sweden, Taiwan, New Zealand and even Russia and China.

Climate and Health Alliance Executive Director Fiona Armstrong, who helped coordinate the survey, said the results showed the Federal Government needed to place far greater emphasis on human health in its approach to climate change.

“As a wealthy country…whose population is particularly vulnerable to the health impacts of climate change, it is very disappointing to see this lack of leadership from policymakers in Australia,” Ms Armstrong said.

Public Health Association of Australia Chief Executive Officer Mike Moore said the increasing number and ferocity of bushfires and storms underlined the urgent need for action.

“It is time to ensure that health-related climate issues are part of our national planning and budgeting if we are to pre-empt many avoidable illnesses and injuries,” Mr Moore said.

Read the AMA’s Position Statement on Climate Change and Human Health.

Adrian Rollins

[Series] Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment

To halt the global tuberculosis epidemic, transmission must be stopped to prevent new infections and new cases. Identification of individuals with tuberculosis and prompt initiation of effective treatment to rapidly render them non-infectious is crucial to this task. However, in settings of high tuberculosis burden, active case-finding is often not implemented, resulting in long delays in diagnosis and treatment. A range of strategies to find cases and ensure prompt and correct treatment have been shown to be effective in high tuberculosis-burden settings.

Imported New World screw-worm fly myiasis

In mid-August 2012, Pamela (not her real name), a university lecturer, visited the Amazon rainforest in north-eastern Peru to conduct a mammal survey, watching and recording wildlife, for a week. She also owned a small sheep farm in Victoria. She had no pre-existing comorbidities.

During her stay in Peru she noticed increasing soreness and a slight discharge behind her right ear. While flying back to Australia, Pamela felt that “things” were moving in a hole behind her right ear, where intense pain was felt intermittently.

Upon arrival in Melbourne, she presented to The Travel Doctor clinic, suspecting that she might have contracted myiasis. On examination, there was an open cavity of about 1 cm in diameter behind her right pinna, filled with maggots wriggling in serous fluid (Box, A). The diagnosis of wound (rather than dermal) myiasis was immediately obvious.

Twenty-three live larvae were extracted from the cavity. After the procedure, the pain subsided significantly and the wound healed within 12 days. At the Victorian Infectious Diseases Reference Laboratory, the maggots were identified as larvae of Cochliomyia hominivorax, the New World screw-worm fly (NWSF). All containers used for transport and storage were autoclaved and destroyed as biological waste.

Human cutaneous myiasis is typically furuncular and confined to dermal tissues. For example, the larvae of the African tumbu and South America bot flies form characteristic localised lesions, each containing one maggot.1 However, typical of wound myiasis, this infection was much deeper, containing multiple larvae.1 NWSF larvae can typically burrow to a depth of 4 cm, producing large cavities as seen in this case.2 The NWSF is attracted to wounds to lay eggs. Unlike most other species of blowflies, adult female screw-worms lay their eggs at the edges of wounds on living, injured mammals.2 Pamela underwent a minor facelift in January 2012, with gathered epithelial tissue behind her ears. Pamela’s site of infection was most likely an abrasion on the skinfold from a hatband.

The main diagnostic feature was the presence of dark pigmentation of the dorsal tracheal tubes extending over 2–3 segments at the posterior end (Box, B).2 The larvae were in the third instar and close to maturity (Box, C).2 Full development takes 5–7 days, after which they fall to the ground to pupate.2

The range of the NWSF is restricted to Central and South America.1,2 Before major eradication campaigns, it extended from the southern states of the United States to Argentina. The NWSF is exotic to Australia and suspicion of infestation in animals is notifiable under state and territory animal health legislation.3 By contrast, screw-worm fly infestation in humans is not notifiable.4

Although the results of surveillance corroborate a low likelihood of incursion into Australia,5 with large feral animal populations in the north and large numbers of livestock along the eastern seaboard, there is a significant possibility of the screw-worm fly becoming established if it manages to gain entry into Australia.68

Biosecurity practices and prompt recognition and reporting of an incursion (Emergency Animal Disease Watch Hotline, 1800 675 888),5,9 are critical to Australia’s preparation for screw-worm flies and other exotic diseases and pests. Pamela’s case reinforces that the risk for Australia is real.

Box –
Wound myiasis from New World screw-worm fly infestation


A: Open cavity behind the patient’s right pinna, filled with maggots. B: Larvae (third instar) of Cochliomyia hominivorax. The main diagnostic feature was the dark pigmented dorsal tracheal tubes at the posterior end of the larvae. C: Larva (third instar) of C. hominivorax. The hook-like mouthpart (on the left) of a live larva constantly strikes with a digging movement inside the host tissue.